Xinying Chang

First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety results of the randomised, phase III CHANGE-2 trial

Ye Guo, Yi Luo, Qingyuan Zhang et al. · European Journal of Cancer · 2021 · 61 citations · Full text

Medicine, Oncology, Chemotherapy +8

Effect of the Novel Selective Progesterone Receptor Modulator Vilaprisan on Ovarian Activity in Healthy Women

Barbara Schütt, Marcus‐Hillert Schultze‐Mosgau, Corinna Draeger et al. · The Journal of Clinical Pharmacology · 2017 · 27 citations · Full text

Medicine, Endocrinology, Pharmacology +17

First‐in‐human study of eliapixant (BAY 1817080), a highly selective P2X3 receptor antagonist: Tolerability, safety and pharmacokinetics

Stefan Klein, Isabella Gashaw, Sybille Baumann et al. · British Journal of Clinical Pharmacology · 2022 · 23 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +9

Pharmacokinetics and Safety of Tedizolid after Single and Multiple Intravenous/Oral Sequential Administrations in Healthy Chinese Subjects

Rui Chen, Kai Shen, Xinying Chang et al. · Clinical Therapeutics · 2016 · 21 citations

Pharmacy, Pharmacokinetics, Pharmacology +8

Adsorption of an Anionic Azo Dye Using <i>Moringa oleifera</i> Seed Protein-Montmorillonite Composite

Mi Xiao, Zhenya Shang, Chunbao Du et al. · Journal of Chemistry · 2019 · 21 citations · Full text

Engineering, Environmental Engineering, Environmental Remediation +16